pyrazines has been researched along with Cor Pulmonale in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (27.27) | 18.7374 |
1990's | 7 (63.64) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (9.09) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dong, YQ; Li, L; Wang, LX | 1 |
Liu, SM; Tang, TQ | 1 |
Duan, SF; Peng, W | 5 |
Li, GS; Sun, BT; Wei, DG | 1 |
Ma, D; Wang, S; Xin, K | 1 |
Peng, W | 1 |
Cui, LH; Duan, SF; Peng, W | 1 |
2 trial(s) available for pyrazines and Cor Pulmonale
Article | Year |
---|---|
[Effects of tetramethylpyrazine on fractalkine and tumor necrosis factor-alpha expression in patients with chronic pulmonary heart disease].
Topics: Aged; Aged, 80 and over; Chemokine CX3CL1; Female; Humans; Male; Middle Aged; Pulmonary Heart Disease; Pyrazines; Tumor Necrosis Factor-alpha | 2010 |
[Clinical and experimental studies of feiyaning in treating pulmonary arterial hypertension in cor pulmonale].
Topics: Adult; Aged; Aged, 80 and over; Animals; Cardiac Output; Cross-Over Studies; Drugs, Chinese Herbal; Female; Humans; Hypertension, Pulmonary; Male; Middle Aged; Pulmonary Heart Disease; Pyrazines; Random Allocation; Rats; Rats, Wistar; Vascular Resistance | 1994 |
9 other study(ies) available for pyrazines and Cor Pulmonale
Article | Year |
---|---|
[Effect of ligustrazine controlled release capsule on hemorrheology in patients with cor pulmonale].
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Blood Viscosity; Delayed-Action Preparations; Female; Fibrinogen; Hematocrit; Humans; Male; Middle Aged; Pulmonary Heart Disease; Pyrazines; Thromboxane B2 | 1993 |
[Effects of ligustrazine on hemodynamics in chronic pulmonary heart disease patients].
Topics: Adult; Aged; Calcium Channel Blockers; Female; Hemodynamics; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Pulmonary Heart Disease; Pyrazines | 1996 |
[Effects of ligustrazine on plasma platelet aggregation rate, thromboxane B2, 6-keto-prostaglandin F1 alpha and von Willebrand's factor in patients with acute onset of cor pulmonale].
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Heart Disease; Pyrazines; Qi; Thromboxane B2; von Willebrand Factor | 1999 |
[Effect of ligustrazine controlled release capsule on pulmonary hemodynamic and right ventricular systolic time intervals in patients with cor pulmonale].
Topics: Administration, Oral; Aged; Aged, 80 and over; Delayed-Action Preparations; Female; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Circulation; Pulmonary Heart Disease; Pyrazines; Systole; Vascular Resistance; Vasodilator Agents; Ventricular Function, Right | 1992 |
Effects of sustained ligustrazine on hemorrheology in patients with chronic pulmonary heart disease.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Aged, 80 and over; Blood Viscosity; Female; Fibrinolytic Agents; Heart Failure; Hematocrit; Humans; Male; Middle Aged; Pulmonary Heart Disease; Pyrazines; Thromboxane B2 | 1992 |
Effects of ligustrazine controlled release capsule in chronic pulmonary heart disease.
Topics: Administration, Oral; Aged; Capsules; Delayed-Action Preparations; Female; Humans; Male; Middle Aged; Pulmonary Circulation; Pulmonary Heart Disease; Pyrazines; Vasodilator Agents | 1991 |
[Evaluation of the immediate effect of ligustrazine in chronic cor pulmonale].
Topics: Adult; Aged; Chronic Disease; Female; Hemodynamics; Humans; Male; Middle Aged; Plethysmography, Impedance; Pulmonary Heart Disease; Pyrazines; Vasodilator Agents | 1989 |
Hemodynamic and hemorrheologic effect of ligustrazini in chronic obstructive pulmonary disease with cor pulmonale.
Topics: Adult; Aged; Female; Hemodynamics; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Plethysmography, Impedance; Pulmonary Circulation; Pulmonary Heart Disease; Pyrazines; Vasodilator Agents | 1987 |
[Ligustrazini in the treatment of chronic cor pulmonale].
Topics: Adult; Aged; Blood Viscosity; Female; Heart; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Heart Disease; Pyrazines | 1987 |